Karen Clements to Medicaid
This is a "connection" page, showing publications Karen Clements has written about Medicaid.
Connection Strength
0.720
-
Clements KM, Clark RE, Lavitas P, Kunte P, Graham CS, O'Connell E, Lenz K, Jeffrey P. Access to New Medications for Hepatitis C for Medicaid Members: A Retrospective Cohort Study. J Manag Care Spec Pharm. 2016 Jun; 22(6):714-722b.
Score: 0.383
-
Clements KM, Kunte PS, Clark MA, Gurewich D, Greenwood BC, Sefton L, Pratt C, Person SD, Wessolossky MA. Uptake of hepatitis C virus treatment in a multi-state Medicaid population, 2013-2017. Health Serv Res. 2022 12; 57(6):1312-1320.
Score: 0.144
-
Chiara AN, Kashalikar N, Pomfret TC, Lenz K, Faber DM, Goldstein J, Clements KM, Angelini MC, Leto P, Jeffrey PL. An Evaluation of a Multidisciplinary Pediatric Behavioral Health Medication Initiative Workgroup's Interventions on Medication Prescribing in a Population of Medicaid Patients. J Manag Care Spec Pharm. 2018 Aug; 24(8):746-751.
Score: 0.111
-
Garcia MM, Lenz K, Greenwood BC, Angelini MC, Thompson T, Clements KM, Mauro RP, Jeffrey PL. Impact of Sequential Opioid Dose Reduction Interventions in a State Medicaid Program Between 2002 and 2017. J Pain. 2019 08; 20(8):876-884.
Score: 0.029
-
Kouris G, Hydery T, Greenwood BC, Lavitas P, Price M, Clements K, Alper CJ, Lenz K, Jeffrey PL. Effectiveness of Ledipasvir/Sofosbuvir and Predictors of Treatment Failure in Members with Hepatitis C Genotype 1 Infection: A Retrospective Cohort Study in a Medicaid Population. J Manag Care Spec Pharm. 2018 Jul; 24(7):591-597.
Score: 0.028
-
Tran S, Lavitas P, Stevens K, Greenwood BC, Clements K, Alper CJ, Lenz K, Price M, Hydery T, Arnold JL, Takeshita M, Bacon R, Peristere JP, Jeffrey PL. The Effect of a Federal Controlled Substance Act Schedule Change on Hydrocodone Combination Products Claims in a Medicaid Population. J Manag Care Spec Pharm. 2017 May; 23(5):532-539.
Score: 0.025